Navigation Links
Pieris Progresses Proprietary Asthma Program: Validation of,Pulmonary Delivery of Anticalin-Based Protein Product Candidate

FREISING-WEIHENSTEPHAN, Germany, July 10, 2007 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, today announced significant progress in validating novel, effective products for the potential treatment of asthma. In studies of its proprietary PRS-060 Anticalin(R) candidate, the Company reports that the protein can be effectively delivered to its target of action via the lungs.

PRS-060 has been selected by Pieris as being specific for a target implicated in a mechanism underlying asthma and other atopic diseases. The mode of action of the Anticalin(R) candidate is via modulation of the site of binding for multiple ligands.

"This important milestone demonstrates the exciting potential of Anticalin(R)-based products for the treatment of respiratory disease," said Dr Andreas Hohlbaum, Director of Science and Preclinical Development of Pieris. "In a simple preclinical biodistribution study quantitating PRS-060 Anticalin(R) delivered via a microspray device, we have already observed about 10-fold higher PRS-060 uptake than that typically obtained with monoclonal antibodies. Our findings have demonstrated the potential to deliver Anticalins(R) through alternative routes to injection and thereby exploit their intrinsic robustness and stability."

"This study confirms the ability of PRS-060 to be formulated in a way ideally suited to its application in asthma, namely in an inhaled preparation for home use," noted Evert Kueppers, Pieris Chief Executive Officer. "These findings continue to support the view that our Anticalin(R) platform, including its recent validation for dual targeting purposes, has enormous potential for application to human diseases that are currently inadequately treated."

The data will be presented for the first time on August 9th 2007 at IBC's Drug Discovery Technology Conference in Bost
'"/>




Page: 1 2

Related medicine technology :

1. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
2. Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin in Preclinical Studies
3. Neurogen Announces Positive Results for Proprietary Insomnia Drug in Two Chronic Insomnia Clinical Trials
4. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
5. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
6. Neurogen Proprietary Insomnia Compound Data Presented at Associated Professional Sleep Societies Annual Meeting
7. Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting
8. Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
9. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
10. Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
11. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
Post Your Comments:
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
(Date:9/22/2014)... Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ... fiscal 2014 ended July 31, 2014 on Monday, September 29 ... discuss the results at 11:00 AM ET. Participating in the ... Andrew A. Krakauer , President and CEO; Jorgen B. ... Sheldon , Senior Vice President, CFO and Treasurer; and ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- New research raises doubts ... cancer. Smokers with cancer who used e-cigarettes along ... those who didn,t use the devices, a Memorial Sloan ... likely -- or less likely -- to have quit ... The study, published online Sept. 22 in Cancer ...
(Date:9/22/2014)... Montreal, Quebec (PRWEB) September 22, 2014 ... understanding of chronic myelogenous leukemia, a form of blood ... CML is caused by a mutation affecting chromosomes 22 ... become a powerful symbol as the worldwide community unites ... it affects. , CML is at the forefront of ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 ... City, has just posted a new article to its ... feel more than just a tad dismayed. Titled “Coffee ... article, http://www.lifeant.com/coffee-drinkers-beware-paying-life-insurance/ states on average, coffee fans ... premiums than those who do not enjoy the tasty ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 As football season ... starting to put together their fantasy football leagues to prep ... also prepping as they work on new ways to bring ... Mica Lounge, located in the Sheraton Silver Spring Hotel, is ... own “Sheraton League” where locals and hotel guests can sign ...
(Date:9/22/2014)... New York, NY (PRWEB) September 22, 2014 ... - Dr. Beth Schrope , NewYork-Presbyterian/Columbia University ... or auto islet surgery, to prevent diabetes in ... is the first center in the New York ... Every year, roughly 87,000 people in the United ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Don't Help Cancer Patients Quit Smoking: Study 2Health News:Marking World CML Day on September 22nd 2Health News:Marking World CML Day on September 22nd 3Health News:Coffee Drinkers Are Charged More For Life Insurance, Reports LifeAnt.com 2Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 2Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 3Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 4Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 2Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 3
... A new study investigating the potential beneficial effects ... of anti-TNFa treatment in aging," appears in the ... ,This study shows hope for significantly ... been linked to blood vessel dysfunction and cell ...
... to your high blood pressure might just be your ... evidence suggests that inflammation, a part of the immune ... diabetes, may also help translate stress into high blood ... is an inflammatory condition,” says Dr. Haidong Zhu, molecular ...
... reduction pill, which works better and faster than existing drugs// ... and cancer. ,Existing anti-obesity pills generally cut weight ... ,But men and women taking Excalia, the new ... lost 12 percent of their body weight, according to the ...
... undergo a double hand transplant was ecstatic as she got ... "I'm doing very well, I'm very happy. I'm taking steps ... life. When I saw the hands after the operation, they ... her arms following an explosion in a laboratory in 1978, ...
... better safety for patients in ICU by adhering to ... threatening// catheter-related infections. ICUs can become thoroughly aseptic by ... syringes and catheters. A detailed report was made by ... of the report are published in New England Journal ...
... more people succumbed to Rift Valley Fever in Garissa district, ... has been made by the North Eastern Provincial// Medical Officer ... cautioned the public to seek medical attention as quickly as ... the disease is due to lack of awareness. But local ...
Cached Medicine News:Health News:Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 3Health News:Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU 2
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Skin Tone External Eyelid Weights...
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
Medicine Products: